Clinical Trial Update: B-19 Parvovirus Vaccine Study [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the B-19 Parvovirus Vaccine (Phase 1/Phase 2) sponsored by NIAID, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parvovirus B19 Infection

Drugs mentioned

• B-19 Parvovirus Vaccine (Parvovirus B19 vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Parvovirus B19 Infection | Phase 1, Phase 2 | Status: TERMINATED